Thomson Reuters | Thursday September 3, 2015
The double-digit stock market gains of pharmaceutical giants including Dr. Reddy's Laboratories and Wockhardt stand out in stark relief to the dismal performance of other Asian emerging-market stocks this year.
Press Trust of India | Wednesday August 26, 2015
The government has brought 18 more drugs, used to treat cancer, inflammation and infections, among others, under price control as part of its efforts to make life saving medicines affordable in the country.
Press Trust of India | Sunday July 26, 2015
Seven of the top ten most valued Indian companies saw a combined erosion of Rs 60,600 crore in market valuation in the week to July 24 on account of correction, with Sun Pharmaceutical Industries taking the hardest hit.
Thomson Reuters | Thursday July 16, 2015
Syngene provides contract drug discovery, research and manufacturing services to 17 of the world's top 20 pharmaceutical companies, including Bristol Myers Squibb & Co and Abbott Laboratories Ltd. Its revenue rose 25 percent in the last three years.
Thursday June 25, 2015
The system aims to facilitate online submission of mandatory returns and reports under the Drug Price Control Order (DPCO), 2013 by manufacturers, including companies which make, import, distribute or sell drugs in the country.
Tuesday June 23, 2015
Innovation and technology will be important differentiators as pharmaceutical companies try to drive growth in emerging markets that face rapid growth of various chronic diseases like diabetes, hypertension, heart disease, and cancer, according to a report.
Sunday June 14, 2015
Amid a weak stock market, the combined market valuation of the top ten Sensex companies has seen an erosion of Rs 54,189 crore in the week to June 12, with IT major Tata Consultancy Services (TCS) being the worst hit.
Sunday May 31, 2015
Top seven Sensex companies lost Rs 33,988 crore in combined market valuation during the week ended May 29, with Sun Pharmaceutical, Reliance Industries (RIL) and HDFC emerging as the biggest losers.
Monday May 4, 2015
With only 41 out of top 100 pharmaceutical firms responding to its direction to register for online database, the National Pharmaceutical Pricing Authority (NPPA) has warned to take action if the rest of the companies did not comply with its order immediately.
Andrew Pollack, The New York Times | Wednesday April 29, 2015
Pharmaceutical companies are racing to develop the first drugs for celiac disease, which researchers say is much more common than previously thought.
Sunday April 19, 2015
The combined market valuation of six of the top ten Sensex companies rose by Rs 53,284.6 crore in the week ended April 17, with Sun Pharmaceutical Industries and Oil & Natural Gas Corp (ONGC) emerging as the biggest gainers.
India News | Press Trust of India | Wednesday April 8, 2015
The government has allowed pharmaceutical companies to hike rates of 509 essential medicines used for treating various ailments like diabetes, hepatitis and cancer by 3.84 per cent with effect from April 1.
Sunday April 5, 2015
The combined market valuation of nine out of top ten Sensex companies advanced by Rs 74,564.28 crore in the week that began on March 30 by with Sun Pharma, ITC and HDFC emerging as the biggest gainers.
Sunday March 15, 2015
The National Pharmaceutical Pricing Authority (NPPA) is still to recover Rs 3,680.43 crore from various pharmaceutical companies for overcharging, while almost 95 per cent of the amount is under litigation.
Sunday March 8, 2015
The m-cap of Sun Pharma surged Rs 26,162.98 crore to Rs 2,14,845.98 crore, the biggest gain among the top-10 Sensex firms.
Monday February 9, 2015
Dishman primarily provides outsourcing services for Active Pharmaceutical Ingredients (API) to large pharma companies and help them in commercialisation of those products.
Saturday December 27, 2014
It has been a year of bitter medicine for Indian pharmaceutical companies with fines worth millions of dollars imposed by various foreign regulators, even as they stitched together deals worth billions of dollars, including a high profile merger between Sun Pharma and Ranbaxy.
Monday December 8, 2014
The Competition Commission of India (CCI) on Monday said it has approved generic drug maker Sun Pharmaceutical Industries Ltd's $3.2 billion bid to buy smaller rival Ranbaxy Laboratories Ltd, subject to the companies divesting seven products.
Tuesday December 2, 2014
Drug major Pfizer on Monday announced completion of its merger with Wyeth Ltd, thereby placing itself among the top ten pharmaceutical companies in India by market share.
Wednesday November 12, 2014
As countries are increasingly focusing on affordable healthcare, Indian pharmaceutical firms are well positioned for global growth, according to a report by global rating agency Standard & Poor's (S&P).
Wednesday November 12, 2014
India's $15 billion pharmaceutical industry, which has been hit by a spate of regulatory sanctions in the past year due to concerns about production processes, supplies about 40 per cent of generic and over-the-counter drugs to the United States.
Thursday October 9, 2014
Indian pharmaceutical companies need to focus on the Latin American markets namely Brazil and Mexico, British brokerage firm Barclays has said.
Sunday October 5, 2014
India's over the counter (OTC) drug market is expected to grow to $6.6 billion by 2016 with pharmaceutical companies and chemists increasing their presence in the rural market.
Friday October 3, 2014
Mergers and acquisitions involving domestic companies jumped to the highest level since 2011 to $26.1 billion during the first nine months this year. They were up 16.5 per cent from the year-ago period.